Molecular responses of human muscle to eccentric exercise

Journal of Applied Physiology

Volumn 95, Issue 6, 2003, Pages 2485-2494

  Chen, Yi Wen ^a   Hubal, Monica J ^b   Hoffman, Eric P ^a   Thompson, Paul D ^c   Clarkson, Priscilla M ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c HARTFORD HOSPITAL   (United States)

Author keywords

c fos; Expression profiling; Immediate early genes; Lipocortin II; Muscle damage

Indexed keywords

ANGIOGENIC FACTOR; ANKYRIN; CHEMOKINE; INTERLEUKIN 1 RECEPTOR; LIGAND; LIPOCORTIN 2; PROTEIN C FOS; TENASCIN;

ADULT; ARTICLE; CAPILLARY; DNA MICROARRAY; ECCENTRIC MUSCLE CONTRACTION; HUMAN; HUMAN EXPERIMENT; HUMAN VERSUS ANIMAL COMPARISON; INFLAMMATION; LEG MUSCLE; MALE; MUSCLE BIOPSY; MUSCLE CAPILLARY; MUSCLE CONTRACTION; MUSCLE EXERCISE; MUSCLE FIBRIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE;

EID: 0344413699     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.01161.2002     Document Type: Article

References (61)

1. Agarwal ML, Agarwal A, Taylor WR, and Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. PNAS 92: 8493-8497, 1995.
2. Aihara Y, Kurabayashi M, Saito Y, Ohyama Y, Tanaka T, Takeda S, Tomaru K, Sekiguchi K, Arai M, Nakamura T, and Nagai R. Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension 36: 48-53, 2000.
3. Ajuebor MN, Hogaboam CM, Le T, and Swain MG. C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse. J Immunol 170: 5252-5259, 2003.
4. Armstrong RB. Initial events in exercise-induced muscular injury. Med Sci Sports Exerc 22: 429-435, 1990.
5. Benevolensky D, Belikova Y, Mohammadzadeh R, Trouve P, Marotte F, Russo-Marie F, Samuel JL, and Charlemagne D. Expression and localization of the annexins II, V, and VI in myocardium from patients with end-stage heart failure. Lab Invest 80: 123-133, 2000.
6. Benjamini Y and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289-300, 1995.
7. 2-terminal kinase activity in human skeletal muscle. J Appl Physiol 87: 1668-1673, 1999.
8. Brown MA, Metcalf D, and Gough NM. Leukemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation. Cytokine 6: 300-309, 1994.
9. Carson JA, Nettleton D, and Reecy JM. Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy. FASEB J 16: 207-209, 2002.
10. Chen YW, Nader GA, Baar KR, Fedele MJ, Hoffman EP, and Esser KA. Response of muscle to acute resistance exercise defined by transcriptional and translational profiling. J Physiol 545: 27-41, 2002.
11. Chen YW, Zhao P, Borup R, and Hoffman EP. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151: 1321-1336, 2000.
12. Cifuentes-Diaz C, Faille L, Goudou D, Schachner M, Rieger F, and Angaut-Petit D. Abnormal reinnervation of skeletal muscle in a tenascin-C-deficient mouse. J Neurosci Res 67: 93-99, 2002.
13. Clarkson PM, Byrnes WC, Gillisson E, and Harper E. Adaptation to exercise-induced muscle damage. Clin Sci (Lond) 73: 383-386, 1987.
14. Dawes NJ, Cox VM, Park KS, Nga H, and Goldspink DF. The induction of c-fos and c-jun in the stretched latissimus dorsi muscle of the rabbit: responses to duration, degree and reapplication of the stretch stimulus. Exp Physiol 81: 329-339, 1996.
15. Ebbeling CB and Clarkson PM. Exercise-induced muscle damage and adaptation. Sports Med 7: 207-234, 1989.
16. Fataccioli V, Abergel V, Wingertsmann L, Neuville P, Spitz E, Adnot S, Calenda V, and Teiger E. Stimulation of angiogenesis by Cyr61 gene: a new therapeutic candidate. Hum Gene Ther 13: 1461-1470, 2002.
17. Fluck M, Chiquet M, Schmutz S, Mayet-Sornay MH, and Desplanches D. Reloading of atrophied rat soleus muscle induces tenascin-C expression around damaged muscle fibers. Am J Physiol Regul Integr Comp Physiol 284: R792-R801, 2003.
18. Goldspink DF, Cox VM, Smith SK, Eaves LA, Osbaldeston NJ, Lee DM, and Mantle D. Muscle growth in response to mechanical stimuli. Am J Physiol Endocrinol Metab 268: E288-E297, 1995.
19. Grzeszkiewicz TM, Lindner V, Chen N, Lam SC, and Lau LF. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparin sulfate proteoglycans. Endocrinology 143: 1441-1450, 2002.
20. Higbie EJ, Cureton KJ, Warren GL III, and Prior BM. Effects of concentric and eccentric training on muscle strength, cross-sectional area, and neural activation. J Appl Physiol 81: 2173-2181, 1996.
21. Hilfiker A, Hilfiker-Kleiner D, Fuchs M, Kaminski K, Lichtenberg A, Rothkotter HJ, Schieffer B, and Drexler H. Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II. Circulation 106: 254-260, 2002.
22. Hortobagyi T, Hill JP, Houmard JA, Fraser DD, Lambert NJ, and Israel RG. Adaptive responses to muscle lengthening and shortening in humans. J Appl Physiol 80: 765-772, 1996.
23. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, and Brown PO. The transcriptional program in the response of human fibroblasts to serum. Science 283: 83-87, 1999.
24. Jarvinen TA, Jozsa L, Kannus P, Jarvinen TL, Hurme T, Kvist M, Pelto-Huikko M, Kalimo H, and Jarvinen M. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci 116: 857-866, 2003.
25. Jarvinen TA, Kannus P, Jarvinen TL, Jozsa L, Kalimo H, and Jarvinen M. Tenascin-C in the pathobiology and healing process of musculoskeletal tissue injury. Scand J Med Sci Sports 10: 376-382, 2000.
26. Jin S, Antinore MJ, Lung FD, Dong X, Zhao H, Fan F, Colchagie AB, Blanck P, Roller PP, Fornace AJ Jr, and Zhan Q. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J Biol Chem 275: 16602-16608, 2000.
27. Johnatty SE, Dyck JR, Michael LH, Olson EN, and Abdellatif M. Identification of genes regulated during mechanical load-induced cardiac hypertrophy. J Mol Cell Cardiol 32: 805-815, 2000.
28. Jones PL and Jones FS. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol 19: 581-596, 2000.
29. Jonsdottir IH, Schjerling P, Ostrowski K, Asp S, Richter EA, and Pedersen BK. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J Physiol 528: 157-163, 2000.
30. Kami K and Senba E. Localization of leukemia inhibitory factor and interleukin-6 messenger ribonucleic acids in regenerating rat skeletal muscle. Muscle Nerve 21: 819-822, 1998.
31. Kanai H, Tanaka T, Aihara Y, Takeda S, Kawabata M, Miyazono K, Nagai R, and Kurabayashi M. Transforming growth factor-β/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Circ Res 88: 30-36, 2001.
32. Kolesnikova TV and Lau LF. Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene 16: 747-754, 1998.
33. Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, and Austin L. The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve 20: 815-822, 1997.
34. Kurek JB, Nouri S, Kannourakis G, Murphy M, and Austin L. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve 19: 1291-1301, 1996.
35. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, and Brown EL. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14: 1675-1680, 1996.
36. MacIntyre DL, Sorichter S, Mair J, Berg A, and McKenzie DC. Markers of inflammation and myofibrillar proteins following eccentric exercise in humans. Eur J Appl Physiol 84: 180-186, 2001.
37. Malm C, Lenkei R, and Sjodin B. Effects of eccentric exercise on the immune system in men. J Appl Physiol 86: 461-468, 1999.
38. Malm C, Nyberg P, Engstrom M, Sjodin B, Lenkei R, Ekblom B, and Lundberg I. Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol 529: 243-262, 2000.
39. Martineau LC and Gardiner PF. Insight into skeletal muscle mechanotransduction: MAPK activation is quantitatively related to tension. J Appl Physiol 91: 693-702, 2001.
40. Michel JB, Ordway GA, Richardson JA, and Williams RS. Biphasic induction of immediate early gene expression accompanies activity-dependent angiogenesis and myofiber remodeling of rabbit skeletal muscle. J Clin Invest 94: 277-285, 1994.
41. Morgan DL and Allen DG. Early events in stretch-induced muscle damage. J Appl Physiol 87: 2007-2015, 1999.
42. Newham DJ, McPhail G, Mills KR, and Edwards RH. Ultrastructural changes after concentric and eccentric contractions of human muscle. J Neurol Sci 61: 109-122, 1983.
43. Newham DJ, Mills KR, Quigley BM, and Edwards RH. Pain and fatigue after concentric and eccentric muscle contractions. Clin Sci (Lond) 64: 55-62, 1983.
44. Nosaka K and Clarkson PM. Changes in indicators of inflammation after eccentric exercise of the elbow flexors. Med Sci Sports Exerc 28: 953-961, 1996.
45. Osbaldeston NJ, Lee DM, Cox VM, Hesketh JE, Morrison JF, Blair GE, and Goldspink DF. The temporal and cellular expression of c-fos and c-jun in mechanically stimulated rabbit latissimus dorsi muscle. Biochem J 308: 465-471, 1995.
46. Pizza FX, Koh TJ, McGregor SJ, and Brooks SV. Muscle inflammatory cells after passive stretches, isometric contractions, and lengthening contractions. J Appl Physiol 92: 1873-1878, 2002.
47. Porter JD, Guo W, Merriam AP, Khanna S, Cheng G, Zhou X, Andrade FH, Richmonds C, and Kaminski HJ. Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle. Neuromuscul Disord 13: 223-235, 2003.
48. Puntschart A, Wey E, Jostarndt K, Vogt M, Wittwer M, Widmer HR, Hoppeler H, and Billeter R. Expression of fos and jun genes in human skeletal muscle after exercise. Am J Physiol Cell Physiol 274: C129-C137, 1998.
49. Reiner A, Yekutieli D, and Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375, 2003.
50. Sekine O, Nishio Y, Egawa K, Nakamura T, Maegawa H, and Kashiwagi A. Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J Biol Chem 277: 36631-36639, 2002.
51. Shadidi KR, Aarvak T, Henriksen JE, Natvig JB, and Thompson KM. The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissue. Scand J Immunol 57: 192-198, 2003.
52. Silzle T, Kreutz M, Dobler MA, Brockhoff G, Knuechel R, and Kunz-Schughart LA. Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol 33: 1311-1320, 2003.
53. Smith LL, Anwar A, Fragen M, Rananto C, Johnson R, and Holbert D. Cytokines and cell adhesion molecules associated with high-intensity eccentric exercise. Eur J Appl Physiol 82: 61-67, 2000.
54. Song G, Campos B, Wagoner LE, Dedman JR, and Walsh RA. Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure. J Mol Cell Cardiol 30: 443-451, 1998.
55. Takahashi H, Kuno S, Miyamoto T, Yoshioka H, Inaki M, Akima H, Katsuta S, Anno I, and Itai Y. Changes in magnetic resonance images in human skeletal muscle after eccentric exercise. Eur J Appl Physiol Occup Physiol 69: 408-413, 1994.
56. Tamura I, Rosenbloom J, Macarak E, and Chaqour B. Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways. Am J Physiol Cell Physiol 281: C1524-C1532, 2001.
57. Taylor WR and Stark GR. Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815, 2001.
58. Toft AD, Jensen LB, Bruunsgaard H, Ibfelt T, Halkjaer-Kristensen J, Febbraio M, and Pedersen BK. Cytokine response to eccentric exercise in young and elderly humans. Am J Physiol Cell Physiol 283: C289-C295, 2002.
59. Trouve P, Legot S, Belikova I, Marotte F, Benevolensky D, Russo-Marie F, Samuel JL, and Charlemagne D. Localization and quantitation of cardiac annexins II, V, and VI in hypertensive guinea pigs. Am J Physiol Heart Circ Physiol 276: H1159-H1166, 1999.
60. Wretman C, Lionikas A, Widegren U, Lannergren J, Westerblad H, and Henriksson J. Effects of concentric and eccentric contractions on phosphorylation of MAPK(erk1/2) and MAPK(p38) in isolated rat skeletal muscle. J Physiol 535: 155-164, 2001.
61. Yang ZH, Kitami Y, Takata Y, Okura T, and Hiwada K. Targeted overexpression of CCAAT/enhancer-binding protein-delta evokes enhanced gene transcription of platelet-derived growth factor alpha-receptor in vascular smooth muscle cells. Circ Res 89: 503-508, 2001.